HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Krause, B. J. Articles by zum Büschenfelde, C. M. Search for Related Content PubMed PubMed Citation Articles by Krause, B. J. Articles by zum Büschenfelde, C. M.

¹⁸F-FDG PET and ¹⁸F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer

¹ Department of Nuclear Medicine, Technische Universität München, Munich, Germany; ² Department of Radiology, Technische Universität München, Munich, Germany; and ³ Department of Internal Medicine, Technische Universität München, Munich, Germany

View larger version (78K): [in this window] [in a new window]   FIGURE 1.  Coronal PET/CT (I), axial PET (II), CT (III), and PET/CT (IV) images of a patient with locally advanced adenocarcinoma of the esophagogastric junction (arrow) before (A) and 14 d after beginning (B) neoadjuvant chemotherapy. Fourteen days after initiation of neoadjuvant chemotherapy, tumor metabolic activity is marginally decreased (<35%). After completion of chemotherapy, more than 50% tumor cells were found in resected specimen.

View larger version (74K): [in this window] [in a new window]   FIGURE 2.  Coronal PET/CT (I), axial PET (II), CT (III), and PET/CT (IV) images of a patient with locally advanced adenocarcinoma of the esophagogastric junction (arrow) before (A) and 14 d after beginning (B) neoadjuvant chemotherapy. Already 14 d after initiation of neoadjuvant chemotherapy, tumor metabolic activity is markedly decreased (>35%). After completion of chemotherapy, no viable tumor cells were found in resected specimen.